GT200500381A - DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT - Google Patents

DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT

Info

Publication number
GT200500381A
GT200500381A GT200500381A GT200500381A GT200500381A GT 200500381 A GT200500381 A GT 200500381A GT 200500381 A GT200500381 A GT 200500381A GT 200500381 A GT200500381 A GT 200500381A GT 200500381 A GT200500381 A GT 200500381A
Authority
GT
Guatemala
Prior art keywords
preparation
derivative
quinolina
product containing
medicinal product
Prior art date
Application number
GT200500381A
Other languages
Spanish (es)
Inventor
Wolfgang Schwede
Antonius Ter Laak
Stefan Jaroch
Benjamin Bader
Roman Hillig
Dieter Sopf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500381A publication Critical patent/GT200500381A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

LA PRESENTE INVENCION SE REFIERE A UN DERIVADO DE QUINOLINA DE LA FORMULA GENERAL A EN LA QUE R1, R2, R3, X, Y, Z Y A SE INDICAN EN LA DESCRIPCION Y EN LAS REIVINDICACIONES, AL USO Y PREPARACIÓN DE LOS COMPUESTOS LA FORMULA GENERAL A PARA EL TRATAMIENTO DE DIVERSAS ENFERMEDADES.THIS INVENTION REFERS TO A QUINOLINE DERIVATIVE OF THE GENERAL FORM A IN WHICH R1, R2, R3, X, Y, ZYA ARE INDICATED IN THE DESCRIPTION AND IN THE CLAIMS, THE USE AND PREPARATION OF THE COMPOUNDS THE GENERAL FORMULA A FOR THE TREATMENT OF DIFFERENT DISEASES.

GT200500381A 2004-12-22 2005-12-21 DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT GT200500381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063223A DE102004063223A1 (en) 2004-12-22 2004-12-22 New quinoline derivatives are ephrin receptor kinase inhibitors useful for the treatment of e.g. blood vessels diseases, hyperproliferations, chronic or acute neurodegenerative diseases, psoriasis, eczema and scleroderma

Publications (1)

Publication Number Publication Date
GT200500381A true GT200500381A (en) 2006-08-03

Family

ID=36599298

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500381A GT200500381A (en) 2004-12-22 2005-12-21 DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT

Country Status (7)

Country Link
CN (1) CN101087788A (en)
AR (1) AR052544A1 (en)
DE (1) DE102004063223A1 (en)
GT (1) GT200500381A (en)
PA (1) PA8657701A1 (en)
SV (1) SV2007002357A (en)
UY (1) UY29308A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382206B (en) * 2012-05-04 2016-09-28 上海恒瑞医药有限公司 Quinoline or quinazoline derivative, its preparation method and in application pharmaceutically
CN106565823B (en) * 2016-11-10 2020-09-11 珠海诺贝尔国际生物医药研究院有限公司 Eph receptor small molecule inhibitor and preparation method thereof
CN110577546B (en) * 2018-06-08 2021-09-07 江苏威凯尔医药科技有限公司 VEGFR inhibitor and preparation method and application thereof
WO2019233458A1 (en) * 2018-06-08 2019-12-12 江苏威凯尔医药科技有限公司 Vegfr inhibitor, preparation method therefor and use thereof
CN113150009B (en) * 2020-01-07 2023-05-23 爱科诺生物医药(香港)有限公司 Heterocyclic compound with activity of inhibiting programmed cell necrosis pathway and application thereof
CN113061142A (en) * 2020-01-02 2021-07-02 爱科诺生物医药股份有限公司 Heterocyclic compounds with programmed cell necrosis pathway inhibition activity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
WO1993003030A1 (en) * 1991-08-02 1993-02-18 Pfizer Inc. Quinoline derivatives as immunostimulants

Also Published As

Publication number Publication date
AR052544A1 (en) 2007-03-21
SV2007002357A (en) 2007-02-16
PA8657701A1 (en) 2006-09-08
UY29308A1 (en) 2006-06-30
DE102004063223A1 (en) 2006-07-13
CN101087788A (en) 2007-12-12

Similar Documents

Publication Publication Date Title
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
UY30327A1 (en) NEW COMPOUNDS II
UY28369A1 (en) THERAPEUTIC AGENTS
CR9954A (en) PIRAZINE DERIVATIVES
UY31481A1 (en) NEW PIRIMIDINE DERIVATIVES, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
CR6726A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
CR9834A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA
UY30460A1 (en) THERAPEUTIC COMPOUNDS
ECSP088296A (en) THERAPEUTIC COMPOUNDS
CR7956A (en) INTERMEDIATE ANTIBACTERIAL INDOLONA OXAZOLIDINONES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HN2008001666A (en) ACID DERIVATIVES OF CICLOALQUILAMINO
CR10304A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS AND PROCEDURES FOR THE SAME USE
UY28671A1 (en) PIRIDO (2.3-D) PIRIMIDINA-2,4-DIAMINAS AS PDE 2 INHIBITORS
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
ECSP088246A (en) NEW DERIVATIVES OF BENZOTIAZOLONA
UY28376A1 (en) THERAPEUTIC AGENTS
UY29648A1 (en) PIRIDOPIRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
GT200600161A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
PA8627001A1 (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28839A1 (en) THERAPEUTIC AGENTS
CR9182A (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT
ECSP099425A (en) DERIVATIVES OF AMINA AND ITS USE IN DISEASES MEDIATED BY THE BETA 2 ADRENORECETOR
HN2003000379A (en) USEFUL ANILINOPIRAZOL DERIVATIVES IN THE TREATMENT OF DIABETES
PA8568101A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE